BRNS Barinthus Biotherapeutics plc.
Healthcare · Market cap: $30.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $10.3K | $0 |
| 2022-Q2 | $50.9K | $72 |
| 2022-Q3 | $0 | $425.2K |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $36.3K |
| 2023-Q2 | $61.0K | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$232.7K6 buy days
Sold$461.6K14 sell days
Net insider flow-$228.9Knet selling · 5 years
Latest trade2023-06-26Scheeren Joseph
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2023-06-26 | Buy | Scheeren Joseph | Director | 10,000 | $2.44 | $24.4K | 1 |
| 2023-05-25 | Buy | Wright Robin | Director | 13,750 | $2.66 | $36.6K | 1 |
| 2023-03-27 | Sell | Enright William | CEO | 15,000 | $2.42 | $36.3K | 1 |
| 2022-08-25 | Sell | Ellis Christopher | COO | 39,176 | $6.57 | $257.4K | 2 |
| 2022-08-25 | Sell | Griffiths Graham | Other C-suite | 10,000 | $7.39 | $73.9K | 1 |
| 2022-08-24 | Sell | Ellis Christopher | COO | 450 | $4.78 | $2.2K | 1 |
| 2022-08-18 | Sell | Ellis Christopher | COO | 2,175 | $4.84 | $10.5K | 1 |
| 2022-08-17 | Sell | Ellis Christopher | COO | 649 | $4.77 | $3.1K | 1 |
| 2022-08-17 | Sell | Griffiths Graham | Other C-suite | 500 | $4.76 | $2.4K | 1 |
| 2022-08-16 | Sell | Ellis Christopher | COO | 2,200 | $4.78 | $10.5K | 1 |
| 2022-08-16 | Sell | Griffiths Graham | Other C-suite | 1,220 | $4.82 | $5.9K | 1 |
| 2022-08-15 | Sell | Ellis Christopher | COO | 5,350 | $4.76 | $25.5K | 1 |
| 2022-08-15 | Sell | Griffiths Graham | Other C-suite | 2,400 | $4.75 | $11.4K | 1 |
| 2022-08-12 | Sell | Griffiths Graham | Other C-suite | 5,000 | $4.50 | $22.5K | 1 |
| 2022-06-28 | Sell | Ellis Christopher | COO | 5 | $6.00 | $30 | 1 |
| 2022-06-23 | Sell | Griffiths Graham | Other C-suite | 8 | $5.28 | $42 | 1 |
| 2022-04-01 | Buy | Scheeren Joseph | Director | 10,000 | $5.09 | $50.9K | 1 |
| 2022-03-31 | Buy | Hammacher Alex | Director | 2,000 | $5.14 | $10.3K | 1 |
| 2021-12-31 | Buy | Hammacher Alex | Director | 1,000 | $10.86 | $10.9K | 1 |
| 2021-12-22 | Buy | Wright Robin | Director | 10,000 | $9.97 | $99.7K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Ellis Christopher | COO | $0 | $309.2K | 2022-08-25 |
| Wright Robin | Director | $136.3K | $0 | 2023-05-25 |
| Griffiths Graham | Other C-suite | $0 | $116.1K | 2022-08-25 |
| Scheeren Joseph | Director | $75.3K | $0 | 2023-06-26 |
| Enright William | CEO | $0 | $36.3K | 2023-03-27 |
| Hammacher Alex | Director | $21.1K | $0 | 2022-03-31 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2021-04-30 → 2021-05-04 | 8 | $12.4M | 45 | +11.1% (+11.7% raw) | +1.6% (+7.4% raw) | -10.8% (+1.2% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.